Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 23:2019:2091960.
doi: 10.1155/2019/2091960. eCollection 2019.

Quality of Life in Painful Peripheral Neuropathies: A Systematic Review

Ayesha Girach  1 , Thomas Henry Julian  1 , Giustino Varrassi  2 , Antonella Paladini  3 , Athina Vadalouka  4 , Panagiotis Zis  5   6
Affiliations

Quality of Life in Painful Peripheral Neuropathies: A Systematic Review

Ayesha Girach et al. Pain Res Manag. .

Abstract

Objective: Neuropathic pain is a common presenting complaint of patients with peripheral neuropathy (PN) and is considered one of the most disabling neuropathic symptoms, with detrimental effects on patients' quality of life (QoL). The aim of this review was to overview the current literature that focuses on QoL in painful PN of various aetiologies. We sought to clarify the direct effect of pain and its treatment on patients' QoL.

Methodology: A systematic computer-based literature search was conducted using the PubMed database to search for papers on QoL in painful PN. Information was extracted regarding prevalence, demographics, and response to treatment where relevant.

Results: We identified 66 articles eligible for inclusion. The vast majority of studies (n=47) focused on patients with diabetic PN. Other aetiologies of painful PN where QoL has been studied to date include gluten, immune-mediated, HIV, chemotherapy-induced, and chronic idiopathic axonal polyneuropathy. Pharmacological treatment is the mainstay in managing pain and has a direct positive and independent effect on the overall QoL. Other nonpharmacological approaches can also be of benefit, either alone or as adjuvant treatments, and are discussed.

Conclusion: The findings demonstrate that QoL is impaired in painful PN and should not be neglected in clinical practice. Patients' pain management and subsequent impact on QoL should routinely be assessed and monitored.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA chart.
See this image and copyright information in PMC

References

    1. Hanewinckel R., Drenthen J., van Oijen M., Hofman A., van Doorn P. A., Ikram M. A. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87(18):1892–1898. doi: 10.1212/wnl.0000000000003293. - DOI - PubMed
    1. Martyn C. N., Hughes R. A. Epidemiology of peripheral neuropathy. Journal of Neurology, Neurosurgery and Psychiatry. 1997;62(4):310–318. doi: 10.1136/jnnp.62.4.310. - DOI - PMC - PubMed
    1. Zis P., Sarrigiannis P. G., Rao D. G., Hewamadduma C., Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. Journal of Neurology. 2016;263(10):1903–1910. doi: 10.1007/s00415-016-8082-7. - DOI - PubMed
    1. Zis P., Paladini A., Piroli A., McHugh P. C., Varrassi G., Hadjivassiliou M. Pain as a first manifestation of paraneoplastic neuropathies: a systematic review and meta-analysis. Pain and Therapy. 2017;6(2):143–151. doi: 10.1007/s40122-017-0076-3. - DOI - PMC - PubMed
    1. Brozou V., Vadalouca A., Zis P. Pain in platin-induced neuropathies: a systematic review and meta-analysis. Pain and Therapy. 2018;7(1):105–119. doi: 10.1007/s40122-017-0092-3. - DOI - PMC - PubMed

Publication types

LinkOut - more resources